One year previously he noted gradually increasing ... A patient with widespread osteoblastic metastases secondary to adenocarcinoma of the lung is described. A persistent hypocalcemia was ...

(RTTNews) - BriaCell Therapeutics Corp. (BCTX), a clinical-stage biotechnology company, on Monday announced the resolution of lung metastasis in the first patient treated with Bria-OTS, a ...

“The results with lorlatinib are the best we’ve ever seen,” he added. “We just haven’t seen results like that in oncology that often, much less in non-small cell lung cancer. These are ...

Brain metastases are one of the most severe complications of melanoma, the most aggressive type of skin cancer. Researchers ...

Investigators conducted a retrospective review that spanned 10 years with the goals of describing the clinical ...

The FDA approved ensartinib (Ensacove) as a first-line treatment for adults with ALK-positive locally advanced or metastatic non-small cell lung cancer (NSCLC), the agency announced on Wednesday.

Then, they tested microrobots on mice with lung-metastasized melanoma by administering four 75 microgram DOX doses over a week. Bioluminescence results indicated that algae-NP(DOX) microrobots ...

Andrew Shepherd said his son Anthony was treated for a lump in a Birmingham hospital during a spell in prison in 2017 and ...

OS Therapies intends to sell the PRV it would earn upon receiving an approval of OST-HER2 for recurrent, fully resected, lung metastatic osteosarcoma. The most recent publicly disclosed sale price ...

OS Therapies (NYSE:OSTX) is up ~65% in premarket trading Wednesday after releasing phase 2b data on OST-HER2 for prevention of recurrent, fully resected, lung metastatic osteosarcoma. Results ...

The findings suggest that reconsideration of current clinical guidelines, which support MRI only for symptomatic brain ...